Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, presented results of the MOMENTUM phase 3 randomized […]

Paymon Bagheri has joined the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, as the senior director of finance and administration. Paymon is a Fellow of the American College of Healthcare Executives (FACHE), Fellow of the American College of Medical Practice Executives (FACMPE) and a certified Lean Six Sigma health […]